Cheil Bio Co

Cheil Bio Co Cash Conversion Cycle

Delisted·Feb 25, 2026

The Cash Conversion Cycle (CCC) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 238.18. In the previous year, Cash Conversion Cycle (CCC) was 114.51 — a change of 107.99% (higher).

Cash Conversion Cycle

238.18

YoY

107.99%

Last updated:

Cash Conversion Cycle (CCC) of Cheil Bio Co is 2023 238.18 . Cash Conversion Cycle (CCC) of Cheil Bio Co was 2022 114.51 . It decreases by 107.99% higher compared to the previous year.

The Cheil Bio Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2016
114.95 KRW
Jan 1, 2017
110.27 KRW
Jan 1, 2018
123.79 KRW
Jan 1, 2019
160.33 KRW
Jan 1, 2020
160.23 KRW
Jan 1, 2021
168.81 KRW
Jan 1, 2022
114.51 KRW
Jan 1, 2023
238.18 KRW
The Cheil Bio Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
238.18+107.99%
114.51-32.16%
168.81+5.35%
160.23-0.06%
160.33+29.52%
123.79+12.26%
110.27-4.07%
114.95-9.33%
126.78+38.64%
91.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Cash Conversion Cycle (CCC) of Cheil Bio Co is 238.18 in 2023.

Cash Conversion Cycle (CCC) of Cheil Bio Co changed from 114.51 to 238.18, representing a 107.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cheil Bio Co

All Key Metrics — Cheil Bio Co